Gene Therapy for Treatment of CRX-Autosomal Dominant Retinopathies The National Eye Institute (NEI) seeks research co-development partners and/or licensees for gene therapy for CRX retinopathies such as Leber congenital amaurosis, retinitis pigmentosa, and cone-rod dystrophy.Therapeutics
